A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1984.tb02491.x/fullpdf
Reference7 articles.
1. Permixon, a new treatment for benign prostatic hyperplasia, acts directly at the cytosolic androgen receptor in rat prostate.;Briley;Br. J. Pharmac.,1983
2. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.;Carilla;J. steroid Biochem.,1984
3. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.;Hammond;J. Endocrinol.,1978
4. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of DHT in the hypertrophic prostate of man.;Siiteri;J. clin. Invest.,1970
5. Inhibition of androgen metabolism and binding by a liposterolic extract of Serenoa Repens B in human foreskin fibroblasts.;Sultan;J. steroid Biochem.,1984
Cited by 121 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Benign Prostate Hypertrophy: An Educational Ultrasound Images and Pharmacotherapy Mini-Review;Journal of Medical Clinical Case Reports;2024-04-23
2. Serenoa repens for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement: An Updated Cochrane Review;The World Journal of Men's Health;2024
3. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement;Cochrane Database of Systematic Reviews;2023-06-22
4. Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts;Uro;2023-01-17
5. The Effect of Epilobium Parviflorum in B.P.H., in Comparison to Tamsulosin and Prazosin;Journal of Pharmaceutical Negative Results;2022-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3